SC 13G
SCHEDULE 13G
- Company
- Chemomab Therapeutics Ltd.
- Filed
- November 21, 2024
- Accession Number
- 0001995601-24-000007
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →